Literature DB >> 25466250

Suppression of TET1-dependent DNA demethylation is essential for KRAS-mediated transformation.

Bo-Kuan Wu1, Charles Brenner2.   

Abstract

Hypermethylation-mediated tumor suppressor gene (TSG) silencing is a central epigenetic alteration in RAS-dependent tumorigenesis. Ten-eleven translocation (TET) enzymes can depress DNA methylation by hydroxylation of 5-methylcytosine (5mC) bases to 5-hydroxymethylcytosine (5hmC). Here, we report that suppression of TET1 is required for KRAS-induced DNA hypermethylation and cellular transformation. In distinct nonmalignant cell lines, oncogenic KRAS promotes transformation by inhibiting TET1 expression via the ERK-signaling pathway. This reduces chromatin occupancy of TET1 at TSG promoters, lowers levels of 5hmC, and increases levels of 5mC and 5mC-dependent transcriptional silencing. Restoration of TET1 expression by ERK pathway inhibition or ectopic TET1 reintroduction in KRAS-transformed cells reactivates TSGs and inhibits colony formation. KRAS knockdown increases TET1 expression and diminishes colony-forming ability, whereas KRAS/TET1 double knockdown bypasses the KRAS dependence of KRAS-addicted cancer cells. Thus, suppression of TET1-dependent DNA demethylation is critical for KRAS-mediated transformation.
Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25466250      PMCID: PMC4268240          DOI: 10.1016/j.celrep.2014.10.063

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  73 in total

1.  TET1 controls CNS 5-methylcytosine hydroxylation, active DNA demethylation, gene transcription, and memory formation.

Authors:  Garrett A Kaas; Chun Zhong; Dawn E Eason; Daniel L Ross; Raj V Vachhani; Guo-Li Ming; Jennifer R King; Hongjun Song; J David Sweatt
Journal:  Neuron       Date:  2013-09-18       Impact factor: 17.173

2.  Promoter methylation of DAP-kinase: association with advanced stage in non-small cell lung cancer.

Authors:  D H Kim; H H Nelson; J K Wiencke; D C Christiani; J C Wain; E J Mark; K T Kelsey
Journal:  Oncogene       Date:  2001-03-29       Impact factor: 9.867

Review 3.  Untangling the ErbB signalling network.

Authors:  Y Yarden; M X Sliwkowski
Journal:  Nat Rev Mol Cell Biol       Date:  2001-02       Impact factor: 94.444

Review 4.  The DNA methyltransferases of mammals.

Authors:  T H Bestor
Journal:  Hum Mol Genet       Date:  2000-10       Impact factor: 6.150

Review 5.  The fundamental role of epigenetic events in cancer.

Authors:  Peter A Jones; Stephen B Baylin
Journal:  Nat Rev Genet       Date:  2002-06       Impact factor: 53.242

Review 6.  Gene-promoter hypermethylation as a biomarker in lung cancer.

Authors:  Steven A Belinsky
Journal:  Nat Rev Cancer       Date:  2004-09       Impact factor: 60.716

7.  Cancer. Addiction to oncogenes--the Achilles heal of cancer.

Authors:  I Bernard Weinstein
Journal:  Science       Date:  2002-07-05       Impact factor: 47.728

8.  Promoter hypermethylation of the O6-methylguanine-DNA methyltransferase gene: more common in lung adenocarcinomas from never-smokers than smokers and associated with tumor progression.

Authors:  Leah C Pulling; Kevin K Divine; Donna M Klinge; Frank D Gilliland; Terri Kang; Ann G Schwartz; Therese J Bocklage; Steven A Belinsky
Journal:  Cancer Res       Date:  2003-08-15       Impact factor: 12.701

9.  RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells.

Authors:  Makoto Suzuki; Noriaki Sunaga; David S Shames; Shinichi Toyooka; Adi F Gazdar; John D Minna
Journal:  Cancer Res       Date:  2004-05-01       Impact factor: 12.701

Review 10.  Targeting RAS signalling pathways in cancer therapy.

Authors:  Julian Downward
Journal:  Nat Rev Cancer       Date:  2003-01       Impact factor: 60.716

View more
  26 in total

1.  p53-Suppressed Oncogene TET1 Prevents Cellular Aging in Lung Cancer.

Authors:  Piotr T Filipczak; Shuguang Leng; Carmen S Tellez; Kieu C Do; Marcie J Grimes; Cynthia L Thomas; Stephanie R Walton-Filipczak; Maria A Picchi; Steven A Belinsky
Journal:  Cancer Res       Date:  2019-01-08       Impact factor: 12.701

2.  TET1: an epigenetic guardian of lymphomagenesis.

Authors:  Kasper Dindler Rasmussen; Kristian Helin
Journal:  Nat Immunol       Date:  2015-06       Impact factor: 25.606

3.  Ten-Eleven Translocation 1 and 2 Confer Overlapping Transcriptional Programs for the Proliferation of Cultured Adult Neural Stem Cells.

Authors:  Koji Shimozaki
Journal:  Cell Mol Neurobiol       Date:  2016-10-24       Impact factor: 5.046

Review 4.  Ten-eleven translocase: key regulator of the methylation landscape in cancer.

Authors:  Jyoti Shekhawat; Kavya Gauba; Shruti Gupta; Bikram Choudhury; Purvi Purohit; Praveen Sharma; Mithu Banerjee
Journal:  J Cancer Res Clin Oncol       Date:  2021-04-28       Impact factor: 4.553

Review 5.  A Tox21 Approach to Altered Epigenetic Landscapes: Assessing Epigenetic Toxicity Pathways Leading to Altered Gene Expression and Oncogenic Transformation In Vitro.

Authors:  Craig L Parfett; Daniel Desaulniers
Journal:  Int J Mol Sci       Date:  2017-06-01       Impact factor: 5.923

Review 6.  Integration of Epigenetic Mechanisms into Non-Genotoxic Carcinogenicity Hazard Assessment: Focus on DNA Methylation and Histone Modifications.

Authors:  Daniel Desaulniers; Paule Vasseur; Abigail Jacobs; M Cecilia Aguila; Norman Ertych; Miriam N Jacobs
Journal:  Int J Mol Sci       Date:  2021-10-11       Impact factor: 5.923

Review 7.  Epigenetic modulators, modifiers and mediators in cancer aetiology and progression.

Authors:  Andrew P Feinberg; Michael A Koldobskiy; Anita Göndör
Journal:  Nat Rev Genet       Date:  2016-03-14       Impact factor: 53.242

Review 8.  Paradoxical roles of dual oxidases in cancer biology.

Authors:  Andrew C Little; Arvis Sulovari; Karamatullah Danyal; David E Heppner; David J Seward; Albert van der Vliet
Journal:  Free Radic Biol Med       Date:  2017-05-31       Impact factor: 7.376

Review 9.  RAS Synthetic Lethal Screens Revisited: Still Seeking the Elusive Prize?

Authors:  Julian Downward
Journal:  Clin Cancer Res       Date:  2015-04-15       Impact factor: 12.531

10.  Ten-Eleven Translocation 1 Promotes Malignant Progression of Cholangiocarcinoma With Wild-Type Isocitrate Dehydrogenase 1.

Authors:  Xuewei Bai; Hongyu Zhang; Yamei Zhou; Katsuya Nagaoka; Jialin Meng; Chengcheng Ji; Dan Liu; Xianghui Dong; Kevin Cao; Joud Mulla; Zhixiang Cheng; William Mueller; Amalia Bay; Grace Hildebrand; Shaolei Lu; Joselynn Wallace; Jack R Wands; Bei Sun; Chiung-Kuei Huang
Journal:  Hepatology       Date:  2021-05       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.